Cyclerion Therapeutics, Inc.
CYCN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $8,108 | $7,832 | $28,510 | $67,328 |
| - Cash | $3,232 | $7,571 | $13,382 | $53,961 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $4,876 | $261 | $15,128 | $13,367 |
| Revenue | $2,000 | $0 | $297 | $3,320 |
| % Growth | – | -100% | -91.1% | – |
| Gross Profit | $2,000 | $0 | -$5,282 | $3,320 |
| % Margin | 100% | – | -1,778.5% | 100% |
| EBITDA | -$3,628 | -$9,582 | -$18,475 | -$53,842 |
| % Margin | -181.4% | – | -6,220.5% | -1,621.7% |
| Net Income | -$3,057 | -$5,263 | -$44,078 | -$51,647 |
| % Margin | -152.9% | – | -14,841.1% | -1,555.6% |
| EPS Diluted | -1.21 | -8.99 | -20.15 | -26.4 |
| % Growth | 86.5% | 55.4% | 23.7% | – |
| Operating Cash Flow | -$4,333 | -$21,245 | -$40,611 | -$36,517 |
| Capital Expenditures | $0 | $0 | $0 | -$7 |
| Free Cash Flow | -$4,333 | -$21,245 | -$40,611 | -$36,524 |